Wednesday, July 8, 2026

biotech · Chronic Hepatitis b · Hepatitis B, Chronic · ABUS

Arbutus Biopharma

Arbutus Biopharma trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

701 Veterans Circle, Warminster, Pennsylvania 18974, US HQ
49 Employees
Public company Type
ABUS · NYSE Ticker
Company details
Status
Public
HQ
701 Veterans Circle, Warminster, Pennsylvania 18974, US
Employees
49
Programs
13
Drugs
7
Patents
56
Intelligence · Clinical Trials

Arbutus Biopharma clinical trials

Registry index of 13 ClinicalTrials.gov studies linked to Arbutus Biopharma programs — each row shows trial ID, program name, phase, status, and indication.

Arbutus Biopharma trial registry — 13 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Arbutus Biopharma.

  1. AB-729-203 — Phase 2

    Clinical update
  2. AB-101-001 — Phase 1

    Clinical update
  3. TKM-100802 for Injection — Phase 1

    Clinical update
  4. TKM-100201 — Phase 1

    Clinical update
  5. AB-836 — Phase 1

    Clinical update
  6. AB-729 — Phase 2

    Clinical update
  7. ARB-001467 — Phase 2

    Clinical update
  8. Imdusiran — Phase 2

    Clinical update

Trial registry

13 studies